Evidence map›Paper›PMID 22686371›Full record

ArticleBiochemistry2012

A model of GAG/MIP-2/CXCR2 interfaces and its functional effects.

Deepa Rajasekaran, Camille Keeler, Mansoor A Syed, Matthew C Jones, Jeffrey K Harrison, Dianqing Wu, Vineet Bhandari, Michael E Hodsdon, Elias J Lolis

Abstract read
In one paragraph

Article in Biochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Heparan Sulfate Proteoglycans in Immunity.Proteoglycan research · 2026
    Article
  2. Article
  3. Review
  4. Coreceptor functions of cell surface heparan sulfate proteoglycans.American journal of physiology. Cell physiology · 2022
    Review
  5. Neutrophils: Amoeboid Migration and Swarming Dynamics in Tissues.Frontiers in cell and developmental biology · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Glycosaminoglycan Interactions Fine-Tune Chemokine-Mediated Neutrophil Trafficking: Structural Insights and Molecular Mechanisms.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Deepa RajasekaranDepartments of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA.
Camille Keeler
Mansoor A Syed
Matthew C Jones
Jeffrey K Harrison
Dianqing Wu
Vineet Bhandari
Michael E Hodsdon
Elias J Lolis
University of Florida · US

Funding

Vascular Pathophysiology and History Core (VPHC)P01HL070694 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COWAN, ANN E. · 2002 to 2013
$17.5M
Signaling Mechanisms for Leukocyte Migration RegulationR01HL108430 · NHLBI · YALE UNIVERSITY · PI WU, DIANQING · 2011 to 2016
$2.4M
Role of Angiogenic Agents in Alveolar Maturation and InjuryR01HL085103 · NHLBI · YALE UNIVERSITY · PI BHANDARI, VINEET · 2009 to 2013
$2.0M
Regulation of CXCR4 by cognate and non-cognate ligandsR01AI082295 · NIAID · YALE UNIVERSITY · PI LOLIS, ELIAS · 2009 to 2013
$2.0M
Functional and Structural Studies of CD74 ActivationR01AI065029 · NIAID · YALE UNIVERSITY · PI LOLIS, ELIAS · 2006 to 2010
$2.0M
Viral-based Chemokine Receptor AntagonistsR01AI058256 · NIAID · UNIVERSITY OF FLORIDA · PI HARRISON, JEFFREY K. · 2006 to 2010
$2.0M
NHLBI NIH HHS P01 HL070694NHLBI NIH HHS R01 HL085103NHLBI NIH HHS R01 HL108430NIAID NIH HHS AI058256NIAID NIH HHS AI065029NIAID NIH HHS AI082295NIAID NIH HHS R01 AI058256NIAID NIH HHS R01 AI065029NIAID NIH HHS R01 AI082295PHS HHS UF06032
6 · The paper itself

Abstract

MIP-2/CXCL2 is a murine chemokine related to human chemokines that possesses the Glu-Leu-Arg (ELR) activation motif and activates CXCR2 for neutrophil chemotaxis. We determined the structure of MIP-2 to 1.9 Å resolution and created a model with its murine receptor CXCR2 based on the coordinates of human CXCR4. Chemokine-induced migration of cells through specific G-protein coupled receptors is regulated by glycosaminoglycans (GAGs) that oligomerize chemokines. MIP-2 GAG-binding residues were identified that interact with heparin disaccharide I-S by NMR spectroscopy. A model GAG/MIP-2/CXCR2 complex that supports a 2:2 complex between chemokine and receptor was created. Mutants of these disaccharide-binding residues were made and tested for heparin binding, in vitro neutrophil chemotaxis, and in vivo neutrophil recruitment to the mouse peritoneum and lung. The mutants have a 10-fold decrease in neutrophil chemotaxis in vitro. There is no difference in neutrophil recruitment between wild-type MIP-2 and mutants in the peritoneum, but all activity of the mutants is lost in the lung, supporting the concept that GAG regulation of chemokines is tissue-dependent.

Indexed as

AlanineAnimalsBronchoalveolar Lavage FluidCells, CulturedChemokine CXCL2Chemotaxis, LeukocyteCrystallography, X-RayDisaccharidesFemaleGlycosaminoglycansHeparinHumansLungMiceMice, Inbred BALB CModels, MolecularAlanineChemokine CXCL2Cxcl2 protein, mouseDisaccharidesGlycosaminoglycansHeparinheparin disaccharideReceptors, Interleukin-8B

Identifiers

PMID22686371
PMCPMC3511906
OpenAlexW2065621942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.